Table 1.
Energy, macronutrient and creatine intake during the study. Values are mean ± SD.
Placebo (n = 11) | GAA (n = 12) | P * | |||||||
---|---|---|---|---|---|---|---|---|---|
Baseline | Week 2 | Week 4 | Week 6 | Baseline | Week 2 | Week 4 | Week 6 | ||
Total energy intake (kcal/day) | 3173 ± 649 | 3492 ± 727 | 3670 ± 716 | 3806 ± 624 | 3467 ± 870 | 3594 ± 984 | 3707 ± 1030 | 3827 ± 886 | 0.59 |
Carbohydrates (%) | 62.1 ± 4.4 | 64.8 ± 5.6 | 65.5 ± 3.7 | 64.9 ± 4.0 | 63.9 ± 5.8 | 64.2 ± 5.2 | 64.4 ± 4.1 | 64.9 ± 4.4 | 0.98 |
Lipids (%) | 23.0 ± 4.1 | 21.4 ± 5.0 | 20.9 ± 3.7 | 20.7 ± 2.8 | 23.2 ± 6.0 | 21.6 ± 4.2 | 21.0 ± 3.7 | 21.8 ± 3.5 | 0.58 |
Proteins (%) | 14.9 ± 3.7 | 13.8 ± 5.0 | 13.6 ± 4.7 | 14.4 ± 4.4 | 12.9 ± 4.3 | 14.3 ± 4.5 | 14.6 ± 4.9 | 13.3 ± 5.0 | 0.45 |
Creatine (g/day) | 0.39 ± 0.08 | 0.42 ± 0.09 | 0.44 ± 0.09 | 0.48 ± 0.08 | 0.39 ± 0.10 | 0.45 ± 0.12 | 0.47 ± 0.13 | 0.45 ± 0.10 | 0.78 |
Note * P value from two-way ANOVA with repeated measures for treatment vs. time interaction.